SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " diagnosis " 426 found 🔀 AI-powered Shuffle
'Something called esophagitis': Kim Kardashian shares health diagnosis in TV show trailer
Kim Kardashian is opening up about a recent health diagnosis in the upcoming season of the show, "The Kardashians."
'Something called esophagitis': Kim Kardashian shares health diagnosis in TV show trailer
Kim Kardashian is opening up about a recent health diagnosis in the upcoming season of the show, "The Kardashians."
Snooki announces that she is cancer-free
‘Jersey Shore’ star Nicole ‘Snooki’ Polizzi announced that she is cancer-free after previously sharing her stage 1 cervical cancer diagnosis.
Kim Kardashian's scary diagnosis hits close to home. What is esophagitis?
Kim Kardashian grapples with a health scare that hits close to home in a new trailer for "The Kardashians." The reality star and fashion mogul reveals in the reality series'
Kim Kardashian's scary diagnosis hits close to home. What is esophagitis?
Kim Kardashian grapples with a health scare that hits close to home in a new trailer for "The Kardashians." The reality star and fashion mogul reveals in the reality series'
Kim Kardashian's scary diagnosis. What is esophagitis?
Kim Kardashian reveals she has been diagnosed with esophagitis in a new trailer for "The Kardashians." The condition, left untreated, can lead to the same cancer that killed her dad.
Heavy caffeine users and deeper sleep; wonders of microscopic life; preparing for life after an Alzheimer’s diagnosis; plus other stories with Vanderbilt Health sources
Beth Malow, MD, Professor of Neurology and Pediatrics in the Vanderbilt Sleep Division, was quoted in Women’s Health about a surprising study from the Journal of Psychopharmacology indicating that heavy caffeine users get deeper non-rapid-eye-movement sleep, even while sleeping less time. The New York Times quoted Dylan Burnette, PhD, Associate Professor of Cell and Developmental Biology, in a story (with videos) about the wonders of the microscopic life all around us. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Prevention (rabies vaccinations); Healthline (update on the Cyclospora outbreak); Prevention again (hundreds now sickened in measles outbreak); and AARP (“How do we know vaccines are safe?” video interview and transcript). Science posted a story about a new NIH research center on vaccine harms. The piece quotes Kathryn Edwards, MD, Professor of Pediatrics, Emerita. Lealani Mae Acosta, MD, MPH, Associate Professor of Neurology, was quoted in an Everyday Health story about how a person, after a diagnosis of Alzheimer’s disease, can enrich their life and prepare for the future. Amalia Peterson, MD, Assistant Professor of Neurology, was quoted by Everyday Health in a piece about common medications linked to lower dementia risk.
Kim Kardashian shares new health diagnosis, and its tragic link to her father's death
Kim Kardashian reveals new health scare with haunting connection to father’s cancer death
Kim Kardashian reveals her esophagitis diagnosis in a new "The Kardashians" trailer, raising fears tied to her father's esophageal cancer death.
Kim Kardashian’s New Health Diagnosis Hits Painfully Close to Home
Kim Kardashian revealed a new health diagnosis in The Kardashians Season 8 trailer, and the moment quickly became personal. Her esophagitis affects the esophagus, the same organ where her late father,...
All About Golfer Brendan Valdes’ Cancer Diagnosis & Health Now
He was diagnosed with non-Hodgkin lymphoma earlier this year.
‘Jersey Shore’ Star Closes the Door on Seven-Month Health Nightmare
Nicole Polizzi shared a major health update seven months after receiving a stage 1 cervical cancer diagnosis, saying doctors found no evidence of disease following her hysterectomy. The Jersey Shore s...
Kim Kardashian reveals new diagnosis — and the link to her father's death at age 59
Kim Kardashian Reveals Esophagitis Diagnosis as Health Scare Brings Back Memories of Her Dad’s Cancer
Kim Kardashian’s latest health scare landed on an especially sensitive subject for her family. In the newly released Season 8 trailer for The Kardashians, Kardashian ... Read More
Kim Kardashian's esophagitis diagnosis raises concerns over dad's death
A recent diagnosis for Kim Kardashian is worrying her inner circle. In a Sept. 17 trailer for Season 8 of "The Kardashians," the Skims founder, 45, is diagnosed with esophagitis.
FDA has too few staffers to hire more staff
FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.
Women’s kidney health may be overlooked, delaying critical prevention and treatment opportunities
Statement Highlights: Diagnosis of women’s chronic kidney disease (CKD) is often delayed, and they are less likely to begin dialysis or receive a kidney transplant. Several female-specific factors impact women’s kidney and cardiovascular health...
How to Prevent a Diagnosis That’s a ‘Silent Assassin’ for the Heart, Cardiologist Warns
In TODAY.com’s Expert Tip of the Day, a cardiologist urges people to prevent a condition that affects millions of Americans and dramatically raises their risk of heart disease.
Susie Wiles make shares MAJOR health update
White House chief of staff Susie Wiles took to X to announce she is cancer-free six months after receiving an early-stage breast cancer diagnosis.
MPH graduate wants to empower women with knowledge about their health
Zeest Mahmood Jalib, MPH ’26, shares how dealing with her diagnosis of PCOS led her to pursue a master's degree in public health.
What Comes Before Stomach Cancer? Researchers Are Finding Out.
Call it a “gut feeling.” For some stomach cancers, the first signs may appear years before a diagnosis. At Sutter Health Research Institute, Dr. Su-Ying Liang is helping lead that work. Through Gastroshare, she and researchers at Stanford University are using artificial intelligence and electronic health record data to study early changes in the stomach […]
A machine learning system that identifies cancer cells based on how they scatter light
Cytology tests are widely used for cancer screening, but diagnosis can be challenging when tumor and non-tumor cells look very similar. Researchers from Japan developed a machine learning system that identifies tumor cells based on their white-light scattering spectra. The approach achieved high diagnostic accuracy for mesothelioma and showed potential for distinguishing several other tumor types, offering a promising approach for enhancing cytological diagnosis.
Celine Dion played her first full concert in 6 years after stiff-person syndrome diagnosis. An incredible high note summed up her triumphant return.
The singer held the climactic high note in "All By Myself" after previously revealing that stiff-person syndrome had left her unable to sing as she had before.
Seahawks Get Troubling Sam Darnold Timeline After New Injury Diagnosis
The Seahawks were dealt some concerning news on Sam Darnold's potential return. The post Seahawks Get Troubling Sam Darnold Timeline After New Injury Diagnosis appeared first on HEAVY.
Bone Health Without the Hype
I am at the Australasian Menopause Society meeting and we had a fantastic lecture on Bone Health on Day 2, called, “Everything you need to know about bones - except the boring bits!” Spoiler alert, there were no boring bits. The lecture was given by Dr. Amanda Beech, who is a senior staff specialist in Obstetric Medicine and Endocrinology at the Royal Hospital for Women, where she is director of the Bone Density Unit. I want to summarize my top 10 take-aways for you. Share Osteoporosis is a disease of low bone mass, disruption of bone microarchitecture, and fragility of the skeleton. It is a silent disease…until someone develops a fracture. The diagnosis of osteoporosis is based on either fragility/minimal trauma fractures or a T-score of less than -2.5 on a DXA (Dual-Energy X-ray Absorptiometry) or bone scan. It is important to recognize that about 50% of minimal trauma fractures occur when women have low bone mass (often referred to as osteopenia), but not osteoporosis. This tells us that bone strength is more complicated than a number on a DXA report. I am going to add a little here that wasn’t in the talk (one can only include so much in 25 minutes), as many women might read the above paragraph and think, “Shouldn’t we be treating everyone with low bone mass if this is when 50% of the fractures occur?” Many fractures happen for women with low bone mass because there are so many women with low bone mass –it is a statement about the population on a whole, not about the fracture risk of low bone mass. For you as an individual, bone density is only one component of fracture risk and many women with lower bone mass will not have a significantly elevated fracture risk. This is why individualized risk assessment matters. Subscribe We build bone in our teens and twenties, and by the time we are about thirty we have reached peak bone mass. This is why, when we discuss risk factors for osteoporosis, it is important to consider factors that might have affected us in our teens and twenties when we were actively building bone, such as nutritional restriction/energy imbalance. It is important to ask women about a history of eating disorders, and for those with such a history, getting a bone scan in perimenopause or at age 50 is likely warranted. (This image below isn’t from the talk, but is similar to one that was). Bone mass is relatively stable until about two years before the final menstrual period, and perimenopause marks a time of rapid bone loss for women. Using urinary markers of bone loss we know that the time of significantly accelerated bone loss starts about 1 year before the final period and ends about 2 years after the final period. The Study of Women’s Health Across the Nation (SWAN) shows that over the menopause transition women lose an average of 10.6% of the bone at their lumbar spine and 9.1% at the femoral neck While this wasn’t covered in the lecture, I want to add that the rapid bone loss during perimenopause is clearly related to more than estradiol, because during this time estradiol levels can be erratic and not uniformly low. Bone loss during perimenopause is likely a multi-hormone event. For example, rising FSH (follicle stimulating hormone) tracks with bone loss better than estradiol, and there is evidence that FSH may act directly on bone. While decreased estrogen matters, there is clearly more going on. FSH and bone is an active area of research. Subscribe Screening for osteoporosis was recommended fairly broadly before age 65, and was taken from the “Practitioner’s Toolkit for Managing Menopause,” from Monash University. Here is a screenshot from the toolkit that was used as a slide: I am going to add a little bit more about body weight here for clarification. Low body mass (typically 152.1 lb): 0 points (risk neutral) 60–69 kg (132.3–152.1 lb): 3 points (adds some risk)
Leukemia patient finishes bone marrow transplant marathon
Just six months after her bone marrow transplant, Taylor Rings ran her first race since a leukemia diagnosis: a 5K in Fargo.
September brings new name for PCOS
Polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome to emphasize metabolic health and improve diagnosis and treatment.
Take Charge of Your Health Today: Safe and affordable housing
JENNIFER THOMPKINS Alzheimer’s disease and other forms of dementia can affect any family, but access to diagnosis, treatment and support is not equal across communities. For many African Americans, the path to care is complicated by limited access to health services, transportation, healthy food, reliable information, and trusted organizations. Those barriers, according to Jennifer Thompkins, president of […]
Rutgers men's basketball coach Steve Pikiell reveals cancer diagnosis
Associate head coach Brandin Knight will be the team's interim coach when Pikiell is absent during the 2026-27 season.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Health Minute: September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month, and in the U.S. the number of new cases continues to increase with the steepest rise in advanced stages of the disease, according to the American Cancer Society. But early diagnosis significantly improves odds of survival. In today’s Health Minute, Mandy Gaither explains why screening is not “one size fits all” and what experts say every man should do when it comes to this cancer.
Bruce Willis’ wife says he’s still ‘very present’ in health update amid dementia battle: ‘Learned to adapt’ (exclusive)
EW has an exclusive look inside Emma Heming Willis’ life with Willis, who still has “beautiful moments of joy and connection” amid “terrible” diagnosis.
Bruce Willis still ‘very present’ amid ‘terrible’ dementia diagnosis (exclusive)
Bruce Willis’ wife, Emma Heming Willis, has given a health update on the actor and how his family ‘learned to adapt’ amid his ‘terrible’ dementia diagnosis: ‘He’s very present.’
Joe Biden shares health update after prostate cancer diagnosis while issuing warning to others
Joe Biden revealed his radiation treatment from last fall "worked as intended" as he urged men to discuss prostate cancer screening with their doctors.
Years of Dismissed Pain, One Life-Changing Diagnosis
Bronx, NY – For 15 years, Jennifer Grant endured pelvic pain, severe nausea, and fainting episodes that no doctor could fully explain or treat. Dismissed
Sinclair's Criminally Obsessed to Present "Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment" National Town Hall to Air on September 9
BALTIMORE – September 8, 2026 – Sinclair today announced a national town hall examining maternal mental health and the questions surrounding diagnosis, treatment and intervention that have been brought into focus by the Lindsay Clancy trial. Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment will stream September 9 across Sinclair’s television station...
Pamela Anderson recalls doctors giving her 10 years to live following hepatitis C diagnosis
‘Baywatch’ alum Pamela Anderson remembers receiving the ‘death sentence’ of a hepatitis C diagnosis and fearing for her sons.
How Art Uncovers the Hidden Pain of Endometriosis
See how ANU PhD candidate Susanne Ilschner goes beyond the diagnosis and clinical data, using abstract paintings to give voice to the unspoken pain of women living with endometriosis.
Cleveland Clinic survey find social media motivates men’s health habits, but carries risk
Cleveland Clinic says social media can motivate men to improve their health, but doctors warn against self-diagnosis and unregulated supplements.
Advancing Women’s Heart Health Through Prevention and Rapid Diagnosis
Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the difference between life and death for women.
Country music star was shocked by her own diagnosis: ‘I didn’t even know’
She made the revelation earlier this year.
Country music star was shocked by her own diagnosis: ‘I didn’t even know’
She made the revelation earlier this year.
“Evil Dead” star Bruce Campbell says he has 5 years left to live after cancer diagnosis
The “Burn Notice” alum said he refuses to fall down a “cancer rabbit hole” and would just “live with it.”
‘Evil Dead’ star Bruce Campbell says he has 5 years left to live after cancer diagnosis
‘Burn Notice’ star Bruce Campbell shared that his doctor estimated that he had about five years to live ‘give or take’ following his cancer diagnosis in March.
Bruce Campbell 'back to the business of living' after wave of support
The Royal Oak-born cult movie icon and 'Evil Dead' star said on a podcast this week he has 5 years to live following his cancer diagnosis.
R&B star is battling cancer at 44. Here’s what we know
The singer recently revealed her diagnosis.
ADHD UK Cannot Hide the Flawed Science Behind the Diagnosis and Its Treatment
The extensive critique of the biomedical account of ADHD and its treatment with stimulant medication has persisted for decades.
Prostate Health: Latest Treatments, Screening Guidelines, More
September is prostate cancer awareness month, so board-certified surgeon Dr. Cedrek McFadden stops by TODAY to share the latest in prostate cancer treatments. He talks about different types of diagnosis, how family genetics come into play, when to get screened, and more.
Sports Hub’s Marc Bertrand reveals cancer diagnosis
“It is treatable, I am an excellent hands, and I am expecting this to soon be behind me in a short amount of time.”
Crazed Times Square stabber's brother reveals long struggle with mental health, possible bipolar diagnosis
What does the Lindsay Clancy trial tell us about treating maternal mental health?
Lindsay Clancy is currently on trial for killing her three children.Prosecutors say the murders were intentional, but her defense team says she was suffering from severe postpartum psychosis -- a condition that does not have a distinct diagnosis in the Diagnostic and Statistical Manual of Mental Disorders.That's the handbook used to identify mental health conditions, so patients often have a hard time getting proper care.The case has put a spotlight on maternal mental health and how its treated by the public and healthcare professionals. What does it reveal?WBUR’s Deborah Becker contributed reporting to this episode.It was produced by Megan Lim and Karen Zamora, with audio engineering by Éowyn Fain, Hannah Gluvna and Ted Mebane. Our director is Jonas Adams.It was edited by Justine Kenin and Tinbete Ermyas.Our interim executive producer is Courtney Dorning.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include bonus episodes and sponsor-free listening. Learn more at plus.npr.org.
First in Utah: Intermountain Health Brings Innovative MRI Technology to Intermountain Medical Center to Enhance Care for Cancer and Heart Patients
Intermountain Medical Center in Murray is the first hospital in Utah – and only the second in the United States – to use an advanced MRI imaging system currently available to help support doctors improve diagnosis for heart and cancer patients.GE HealthCare’s SIGNA Sprint Elite MRI is an innovative imaging system that utilizes advanced tec...
Brain scan method may improve diagnosis, treatment of psychosis
Vanderbilt Health study identifies two previously unreported subtypes of psychosis based on an analysis of structural brain scans.
Sandra Bullock explains how she talked to her kids about her late partner’s ALS
Sandra Bullock explains that her two kids handled her late partner Bryan Randall’s ALS diagnosis very differently.
Lil Nas X’s bipolar diagnosis and the paradox of treatment
We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.
Why 'science-backed' is becoming an important label in wellness
Social media is the go-to place for wellness content today. Influencers promote everything from health tips to supplements and provide education on numerous health issues. Wellness content has even led viewers to seek help or get a diagnosis. However, wellness content is largely riddled with misinformation and conflicting advice. Influencers are encouraged to make
Endometriosis diagnosis linked to long-lasting mental health burden
Women who are later diagnosed with endometriosis have a markedly higher use of antidepressant and anxiety medication and are far more often in contact with psychiatric hospital departments than other ...
Queen Camilla opens up on keeping King Charles cancer diagnosis secret
Queen Camilla is opening up on the difficulty of keeping royal secrets.
Closing the Gap in Women’s Health Research
Hologic’s Mary Byerly on why many conditions that affect women remain understudied, how sex differences shape diagnosis, and what collaboration can change.
Health care experts urge caution when using AI for self-diagnosis
Despite its limitation, AI can still be a great tool, Momaya said.
Business People
Benjamin Schurhamer, MD, recently joined Washington Regional Ozark Urology, where he provides diagnosis and treatment of urological conditions with a focus on cancers of the prostate, bladder and kidney.
How to Support Your Partner Through a Health Crisis
A surprise diagnosis can change a relationship overnight. Here’s how to show up for your other half without losing sight of yourself.
AI needs science’s search history
“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.
Twelve U.S. Health Systems and Aidoc Unite to Confront America’s Diagnostic Capacity Crisis
As demand for diagnostic answers outpaces the physicians available to deliver them, health systems are collaborating with Aidoc on a shared goal: helping patients receive a safe, accurate diagnosis sooner.
Experts Talk Postpartum Psychosis Symptoms and Diagnosis Amid Lindsay Clancy Trial
Whether Lindsay Clancy was suffering from undiagnosed postpartum psychosis when she killed her three children is central to her defense. Her Massachusetts murder trial is ongoing.
Basketball Hall of Famer Dick Vitale Issues Health Update After 5th Cancer Diagnosis
Beloved ESPN college basketball analyst and Naismith Memorial Basketball Hall of Famer Dick Vitale had personal news that was bound to affect millions of basketball fans over the globe. The 87-year-old announced in April, earlier this year, that he was diagnosed with cancer for the fifth time… Fortunately, Vitale, affectionately known as Dickie V, is on his way to becoming cancer-free for the fifth time.
Iconic 49ers RB Roger Craig announces he has vascular dementia during Hall of Fame speech: 'This diagnosis doesn't define me'
Law and science collide in federal lawsuit over social media addiction
Attorneys for Meta and other companies have argued that because social media addiction has not been formally recognized by the medical community, they cannot be held liable when sued over it. But the standard for a diagnosis is changing, and judges have been skeptical of those arguments.
Viewpoint: Europe needs a new scientific contract
The White House's new science strategy should be required reading in the Berlaymont and every European capital.Not because Europe should copy it. Parts of it should concern Europeans deeply. But because it asks the question Europe has so far avoided while steadily losing ground in the global race for technological leadership.Europe already possesses many of the world's finest universities, scientists and research-intensive companies. It produces world-leading research in fields ranging from quantum technologies and biotechnology to climate science. Yet time and again Europe generates the scientific breakthroughs while others build the companies, industries and strategic advantages around them, particularly in digital technologies. Increasingly, we find ourselves regulating technologies whose underlying capabilities were developed elsewhere.This is not primarily a scientific failure. It is an institutional one.The settlement that shaped modern science policy emerged after the Second World War. In Science, the Endless Frontier, Vannevar Bush argued that governments should invest in fundamental research while protecting scientists from political direction. Public investment was justified precisely because no government, university or company could predict where the next transformative discovery would emerge.That scientific contract served liberal democracies extraordinarily well. It underpinned decades of advances in medicine, computing, energy and communications, but the world for which it was designed no longer exists.Artificial intelligence is transforming not only technology but the production of knowledge itself. Advanced chips, computing power, data and scientific instruments have become strategic assets. Scientific knowledge now diffuses globally almost instantly. Competitive advantage increasingly lies not in making discoveries first, but in possessing the infrastructure, capital, engineering capability and institutions required to translate those ideas into products, industries and strategic advantage.The old boundaries between science, industrial policy, national security and geopolitics have largely disappeared. Dual-use technologies now underpin both economic power and military deterrence.The US has recognised this shift. In July, the White House published Science: A New Golden Age, a comprehensive attempt to rethink the relationship between science and national power. The report builds on Bush's legacy, but departs from his framework in important ways. Science is no longer treated simply as the source of future discoveries. It is presented as the foundation of economic resilience, technological leadership and national security. AI, advanced infrastructure and the capacity to build become as important as discovery itself.Yet the report also reveals a striking paradox. The same administration calling for “a new golden age” of US science has simultaneously proposed deep cuts to the federal research enterprise while expanding political influence over the allocation of public research funding. Europe should therefore distinguish between the report's diagnosis and its prescription. The diagnosis, that science has become a strategic asset, is compelling. But the prescription is self-defeating. Long-term technological leadership depends on strong universities, academic freedom and the institutional autonomy that makes scientific discovery possible. This distinction matters. Bush's achievement was never simply to make science serve national strength. It was to establish a division of labour in which governments invested in research without attempting to direct discovery itself. Scientific breakthroughs emerge precisely because researchers retain the freedom to pursue questions whose value cannot yet be demonstrated and whose conclusions cannot be anticipated.Neither China, nor the USAs science becomes more strategically important, the temptation to politicise it inevitably grows. But scientific freedom is not an obstacle to technological leadership, it is an essential precondition.China represents the opposite model. For decades it has integrated science, manufacturing, infrastructure and industrial policy into a single national strategy. Its ability to mobilise resources around critical technologies is formidable. But it does so within an authoritarian system where scientific priorities are increasingly inseparable from political power.Europe should imitate neither model. It should learn from the strategic ambition of the US without importing its growing politicisation of science. And it should learn from China's capacity to build without adopting its concentration of power.Instead, Europe needs a scientific contract of its own. Bush's scientific contract protected the freedom to discover because the defining challenge of the 20th century was producing new knowledge. Europe's next scientific contract must preserve that freedom while ensuring that scientific discoveries can be converted into technological, industrial and strategic capability. Because in a transactional world, Europe's freedom to shape its own future depends on its capacity to build it.Related articlesThe US ‘golden age’ science strategy: what Europeans need to knowEuropean researchers sound the alarm that Trump rule changes will hit cooperationNIH turmoil risks reciprocal EU-US access to health research fundingThis does not mean subordinating free science to competitiveness or industrial policy. On the contrary. Scientific autonomy remains the first principle of Europe's next scientific contract. Governments should not direct scientific discovery. Their responsibility is to ensure that Europe's scientific, industrial, financial and regulatory institutions work together rather than in isolation.Meeting that responsibility requires far more than research funding. European researchers need access to world-class computing infrastructure, advanced laboratories, shared datasets and scientific facilities. Innovative companies need patient capital, testing environments and a genuine single market in which they can scale without facing 27 different regulatory regimes. Public procurement must evolve from purchasing existing technologies to creating markets for new ones. Regulators must become partners in experimentation rather than guardians of yesterday's rules.A connecting architectureEurope does not need to invent the Defense Advanced Research Projects Agency (Darpa) model from scratch. Britain's Aria, Germany's Sprind and Wellcome Leap already show that Europe can build institutions capable of taking high-risk, mission-oriented bets while preserving democratic accountability. The challenge now is not to create more isolated initiatives, but to connect them to Europe's broader scientific, industrial and financial system so that breakthrough discoveries can scale.Above all, Europe must stop treating research, innovation, industrial policy, finance and security as separate policy domains. The challenge is no longer to create excellent institutions in each of these fields, but to make them work as one European innovation system. Europe's strength will increasingly depend not on excellence within institutions, but on excellence across them.Europe's ambition should be neither to imitate the US nor to emulate China. It should demonstrate that scientific freedom, democratic legitimacy and technological capability are not competing objectives, but mutually reinforcing strengths. In an age of geopolitical rivalry, Europe's greatest advantage may ultimately be its ability to attract the world's best talent by combining scientific freedom, democratic openness and technological ambition.Bush's scientific contract helped define the 20th century because it protected the freedom to discover. Europe's challenge is not to abandon that achievement but to extend it. The defining task of Europe's next scientific contract is to preserve the freedom to discover while building Europe's capacity to translate scientific discovery into technological power.Kaare Nielsen is founder of Pomus, a Danish think tank on science and innovation.
Consumer Reports: AI chatbots can mislead users seeking health information
AI health advice can sound reassuring, but experts warn it may be wrong. Use chatbots as a starting point, not a diagnosis.
Complete Health to pay $14M to settle Medicare Advantage fraud allegations
The value-based primary care provider submitted false diagnosis codes to the CMS for three years, inflating its reimbursement by millions of dollars, according to the DOJ.
Douglas Flora: How Science Turned a Stage IV Lung Cancer Diagnosis Into 12 Years of Hope
Douglas Flora: How Science Turned a Stage IV Lung Cancer Diagnosis Into 12 Years of Hope / cancer, cancer care, Cancer research, cancer screening, cancer
Former Raptor Chris Bosh Sends Encouraging Message To Victor Wembanyama
Bosh, who has dealt with blood clots, extended his advice to Wembanyama, who has also dealt with the diagnosis.
Jacksonville-based Complete Health to pay $14M in Medicare Advantage settlement
Complete Health Partners Holdings has agreed to pay $14.1 million to settle allegations that it caused false diagnosis codes to be submitted to boost payments from the Medicare Advantage program, the Department of Justice said.
Panama: Haemophilus influenzae meningitis case reported in Veraguas Health Region
The Veraguas Health Region, located in the central-western region of Panama, confirmed a case of meningitis caused by the Haemophilus influenzae bacteria in a 12-year-old student from La Primavera School, diagnosed on July 29. The patient remains hospitalized, is receiving appropriate treatment, and is in stable clinical condition. The regional health director of Veraguas, Xavier A. Torres Domínguez, reported that, once the diagnosis was confirmed, the Ministry of Health (Minsa), in coordination with the Social Security Fund (CSS), immediately activated the epidemiological investigation and health response protocols established for this type of event. Canada: Haemophilus influenzae type B outbreak in Calgary As part of the actions implemented, the Epidemiology teams carried out the identification and monitoring of the patient’s close contacts, applying the corresponding preventive measures to reduce the risk of transmission and safeguard the health of the educational community. Health authorities explained that meningitis caused by Haemophilus influenzae is a bacterial disease that requires timely medical attention. In that regard, they urged the population to immediately seek medical attention if they experience symptoms such as high fever, severe headache, stiff neck, vomiting, drowsiness, or altered mental status. They also reiterated that vaccination is the main preventive measure against this disease, and therefore called on parents and guardians to verify that their children’s immunization schedules are complete, in accordance with the Expanded Program on Immunization (EPI). Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Chile declares health alert for hantavirus
The Chile Ministry of Health issued a Health Alert for hantavirus and other diseases, such as some arboviruses and avian influenza. This is the first time this measure has been taken and it will be in effect until July 31, 2027 and it extends from the Atacama region to the Magallanes region. “Hantavirus causes a disease that is endemic to Chile, transmitted by the long-tailed pygmy rice rat that lives in rural and semi-rural areas throughout almost the entire country. As a ministry, we are constantly monitoring its behavior and are very concerned and actively working because this year the virus's lethality has increased, and for this reason, we decided to declare this alert. As of last week, there were 46 confirmed cases and 18 deaths, representing a 39% lethality rate,” reported the Undersecretary of Public Health, Dr. Alejandra Pizarro. Cases have occurred in the regions of Valparaíso, Metropolitan, O'Higgins, Maule, Ñuble, Biobío, La Araucanía, Los Ríos, Los Lagos, and Aysén. By comparison, in 2025, there were 44 infections and eight deaths (18% case fatality rate). The health alert, which is preventative and prepared, will allow for the granting of extraordinary powers in the event of serious health emergencies to strengthen surveillance, ensure timely resource management, hire specialized personnel, implement health control measures, and expedite the acquisition of supplies through direct procurement. The alert does not imply that there is an ongoing epidemic or that the healthcare system is overwhelmed. Subscribe to Outbreak News TV on YouTube “Hantavirus is not exclusively a summer virus, as the long-tailed pygmy rice rat is present year-round. Therefore, we urge everyone to take extreme precautions: avoid touching rodents, ventilate homes before entering if they have been closed, clean unused spaces with water and bleach, and keep garbage covered and food stored away. Furthermore, it is crucial to be aware of the symptoms: fever, intense muscle pain, and difficulty breathing. If someone experiences these symptoms and has been in rural or semi-rural areas where the long-tailed pygmy rice rat may have been present, they should immediately go to a health center and inform the medical staff so that a hantavirus diagnosis can be considered promptly,” the official added. Since December 2025, the Pan American Health Organization (PAHO) has maintained an epidemiological alert due to the rise in hantavirus cases throughout the Southern Cone, and that the Ministry of Health had an epidemiological alert in place since November of last year. Chile eliminates leprosy As mentioned above, the Health Alert decree also covers diseases transmitted by the Aedes aegypti, Aedes vexans, and Anopheles pseudopunctipennis mosquitoes, such as dengue and Zika, which, according to the alert, “have a high epidemic potential, which could generate high demand and overload for health facilities.” For these diseases, the alert is in effect from Arica to Los Ríos. The authority stressed that it is essential to prevent mosquitoes from breeding in stagnant water and to monitor any suspected cases of people arriving from abroad infected with any of these diseases, in order to prevent any of these vectors from biting a sick person and starting to spread the disease. In the case of avian influenza, the alert was extended to the entire country, because unlike other years, the disease has been concentrated in wild and farm birds, not in poultry farms, increasing the risk of exposure for people. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
After PCOS became PMOS, there's hope for new awareness among Black and Latina women
Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high prevalence and low diagnosis.
Carly Simon explains ‘difficult, frustrating’ diagnosis with Parkinson’s after skin cancer
Carly Simon revealed a major health update amid her ‘difficult, frustrating’ diagnosis with Parkinson’s disease, which followed surgery for skin cancer: ‘I am still very much here.’
Carly Simon Reveals Parkinson’s Diagnosis
“I have learned to accept that every day will look a little different. But I am still very much here,” the singer said in a statement to NBC News.
AI mental health chatbots feel empathetic, but safety evidence still lags
Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, altered neuroimmune signaling, genetic susceptibility, and stress-related epigenetic changes. Evidence also suggests that biologically defined patient subgroups may benefit from more precise, immune-informed approaches to diagnosis and treatment.
Wellumio raises nearly $10M to advance point-of-care MRI system
Axana is designed to bring point-of-care stroke diagnosis to emergency departments and other acute care settings.
‘Game-changing’ spit test could shrink years-long wait for diagnosis of condition that affects 190M women
Country star Waylon Wyatt says he nearly 'died' after sudden health crisis derailed his Grand Ole Opry debut
Waylon Wyatt shared a video from his hospital bed after announcing his sepsis diagnosis on the same day his debut album "Dustpiles" dropped.
The event that turned an aerospace engineer into an AI founder
After her aunt's cancer diagnosis upended her family, Lily Vittayarukskul built an AI startup to help others prepare for long-term care.